By admin Research Triangle Park, NC, May 23, 2013 – Adherex Technologies Inc. (TSX:AHX, OTCQB: ADHXF), today announced that it has received feedback from the FDA at an End-of-Phase 2 meeting held yesterday. During the FDA meeting, Adherex reviewed the opportunity that eniluracil offers to Metastatic Breast Cancer (MBC) patients who had rapid disease progression on capecitabine. […]
- Home
- Contact
- News
- Top Warrants by PCT Gain
- content
Top 5 Gainers for Warrants by % Change
Symbol Close WT Symbol WT Close % Change
- content
- Most Active Warrants
- activeContent
Top 5 Most Active Warrants by Volume
Symbol Close WT Symbol WT Close WT Volume
- activeContent
- Database Filter
- DB Filter Content
Select your filters from the available options:
- DB Filter Content
- Subscriber Content
- Subscontent
Subscriber Content
After subscribing to the service (All Levels) this menu will become active to direct you to member database locations and weekly audio recordings. Please refresh the page if you have subscribed and are still seeing this message.Always remember to stay abreast of changes with the underlying security and the expiration date.
GET BETTER RESULTS BY UPGRADING TODAY!​
- Subscontent